"
Team:Penn/Project2
From 2013.igem.org
| (One intermediate revision not shown) | |||
| Line 35: | Line 35: | ||
<ul class="navbar"> | <ul class="navbar"> | ||
| - | <li><a href="https://2013.igem.org/Team:Penn"> | + | <li><a href="https://2013.igem.org/Team:Penn">HOME</a></li> |
<li class="dropdown" id="project"> | <li class="dropdown" id="project"> | ||
| - | <a href="#" class="active" data-toggle="dropdown"> | + | <a href="#" class="active" data-toggle="dropdown">PROJECT<div class="arrow">></div> <b class="caret"></b></a> |
<ul class="dropdown-menu" id="drop-menu1"> | <ul class="dropdown-menu" id="drop-menu1"> | ||
| Line 47: | Line 47: | ||
</li> | </li> | ||
<li class="dropdown" id="about"> | <li class="dropdown" id="about"> | ||
| - | <a href="#" class="dropdown-toggle" data-toggle="dropdown"> | + | <a href="#" class="dropdown-toggle" data-toggle="dropdown">ABOUT<div class="arrow">></div> <b class="caret"></b></a> |
<ul class="dropdown-menu" id="drop-menu2"> | <ul class="dropdown-menu" id="drop-menu2"> | ||
<li><a href="https://2013.igem.org/Team:Penn/Team">team</a></li> | <li><a href="https://2013.igem.org/Team:Penn/Team">team</a></li> | ||
| Line 54: | Line 54: | ||
</li></ul> | </li></ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Penn/HumanPractices"> | + | <li><a href="https://2013.igem.org/Team:Penn/HumanPractices">HUMAN PRACTICES</a></li> |
| - | <li><a href="https://2013.igem.org/Team:Penn/Notebook"> | + | <li><a href="https://2013.igem.org/Team:Penn/Notebook">NOTEBOOK</a></li> |
</ul> | </ul> | ||
| Line 69: | Line 69: | ||
<div class="content2"> | <div class="content2"> | ||
| - | <h2> | + | <h2>ABSTRACT</h2> |
<p>The code of life is much more than a sequence of A's, G's, C's and T's; | <p>The code of life is much more than a sequence of A's, G's, C's and T's; | ||
| Line 87: | Line 87: | ||
fusion protein that enables site-specific methylation, which can repress promoter activity with | fusion protein that enables site-specific methylation, which can repress promoter activity with | ||
high precision. <div class="figure-wrap" style="float: center;"><img src="https://googledrive.com/host/0B4ZBZOYYKBzEdmZMalozd0pkSjg" style="height: 75px; margin: 5px; float: left;"/> | high precision. <div class="figure-wrap" style="float: center;"><img src="https://googledrive.com/host/0B4ZBZOYYKBzEdmZMalozd0pkSjg" style="height: 75px; margin: 5px; float: left;"/> | ||
| - | <img src="https://googledrive.com/host/0B4ZBZOYYKBzEdlExOEgtVlZYYUU" style="height: 75px; float: left; margin: 5px;"/></div>In coming years, this fusion protein could become a powerful tool for epigenetics | + | <img src="https://googledrive.com/host/0B4ZBZOYYKBzEdlExOEgtVlZYYUU" style="height: 75px; float: left; margin: 5px;"/></div><p>In coming years, this fusion protein could become a powerful tool for epigenetics |
researchers looking to perform on/off studies in the vein of classical genetics, as well as an | researchers looking to perform on/off studies in the vein of classical genetics, as well as an | ||
orthogonal mode of repressing constitutive promoters for bacterial synthetic biologists. | orthogonal mode of repressing constitutive promoters for bacterial synthetic biologists. | ||
Latest revision as of 20:19, 11 August 2013
ABSTRACT
The code of life is much more than a sequence of A's, G's, C's and T's; a suite of epigenetic mechanisms, ranging from chromatin remodeling to non-coding RNAs, affect gene expression and cellular function.
In particular, DNA methylation has been shown to alter transcriptional activity in a powerful, heritable manner. Abnormal methylation patterns are associated with diseases including immunodeficiency syndromes, neurodevelopmental disorders, and many types of cancer. Comprehensive understanding and control of DNA methylation could be invaluable to researchers studying these diseases.
Synthetic biologists and geneticists are accustomed to turning genes on and off at will, but the tools don’t exist to easily manipulate epigenetic patterns. We are developing a novel fusion protein that enables site-specific methylation, which can repress promoter activity with high precision.
In coming years, this fusion protein could become a powerful tool for epigenetics researchers looking to perform on/off studies in the vein of classical genetics, as well as an orthogonal mode of repressing constitutive promoters for bacterial synthetic biologists. Eventually, it could even give clinical researchers the means to restore healthy methylation levels in many insofar-untreatable epigenetic diseases.
